Results 171 to 180 of about 72,402 (211)
Some of the next articles are maybe not open access.
The dilemmas of a carrier of BRCA1 gene mutations
Patient Education and Counseling, 1998This article describes that the decision to be tested on carriership of hereditary cancer has consequences that are more far-reaching than a potential carrier can anticipate beforehand. The experiences of a 41 year old woman, carrier of a mutated BRCA1 gene, who shortly before her scheduled bilateral breast amputation, decided not to have surgery, are ...
openaire +2 more sources
Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women
Journal of Cancer Research and Clinical Oncology, 2009BRCA1-interacting protein C-terminal helicase 1 (BRIP1) and zinc finger protein 350 (ZNF350) work with BRCA1 in tumor suppression procedures. Low penetrance variants of these three genes may jointly affect individuals' breast cancer susceptibility in general population.We focused on potentially functional single nucleotide polymorphisms (SNPs) in the ...
Xiang, Huo +10 more
openaire +2 more sources
The BRCA1 and BRCA2 breast cancer genes
Current Opinion in Oncology, 1997Between 5% and 10% of breast cancer cases result from an inherited predisposition. The majority of hereditary forms of breast and ovarian cancer can be accounted for by mutations in two recently identified genes, BRCA1 and BRCA2. Inactivating mutations have been found throughout both genes, and the majority are predicted to result in truncated proteins.
openaire +2 more sources
Analysis of the BRCA1 and BRCA2 genes in sporadic meningiomas
Genes, Chromosomes and Cancer, 1997Several lines of evidence suggest a relationship between the occurrence of meningiomas and that of breast carcinomas: Both occur more frequently in women than in men, and a higher incidence of meningiomas has been observed in patients with a history of breast carcinoma.
M, Kirsch, J J, Zhu, P M, Black
openaire +2 more sources
BRCA1 Gene Sequence Variation in Centenarians
Annals of the New York Academy of Sciences, 2001Abstract: With the ample gene sequence information that has become available with the human genome project virtually completed, it has become possible to identify functional gene variants and their frequencies in elderly populations with different aging‐related characteristics.
J, Vijg +3 more
openaire +2 more sources
BRCA1 and BRCA2 - breast cancer susceptibility genes
Journal of Cancer Research and Clinical Oncology, 2000Genetic predisposition is responsible for 5% 10% of all breast cancer cases. Therefore, the inherited susceptibility to breast cancer has been intensively investigated during the last 10 years. In particular, the identification of the breast cancer susceptibility genes BRCA1 (breast cancer gene 1) and BRCA2 and the current genetic testing for mutations
W, Hofmann, P M, Schlag
openaire +2 more sources
Males at‐risk for the BRCA1-gene, the psychological impact
Psycho‐Oncology, 1996In recent literature the psychological impact of predictive DNA-testing for Hereditary Breast and Ovarian Cancer (HBOC) for male individuals at-risk has not been considered. We have observed that confrontation with the hereditary nature of breast/ovarian cancer does have a psychological impact on males at-risk.
de Wit, A. C. D. +5 more
openaire +2 more sources
BRCA1 Gene Mutation in Thymic Malignant Melanoma
The Annals of Thoracic Surgery, 2013We present a patient with triple primary malignancies: thyroid cancer, ovarian cancer, and thymic malignant melanoma. We suspected that gene mutations were involved in the occurrence of these multiple primary cancers, and blood analysis revealed the presence of BRCA1 gene mutations.
Eun Jue, Yi +5 more
openaire +2 more sources
Premature Menopause in Patients with BRCA1 Gene Mutation
Breast Cancer Research and Treatment, 2006This study was undertaken with regard to the gonadotropin theory of ovarian cancer advocated in the literature and was designed to disclose specific features of ovarian morphology in carriers of the BRCA1 gene mutation. We enrolled 171 patients and divided them into two groups: A (n=90)--operated for breast cancer (30 patients with and 60 without the ...
Izabella, Rzepka-Górska +5 more
openaire +2 more sources
Gene Therapy for Breast and Ovarian Cancer with BRCA1
Breast Disease, 1998As an initial step toward gene therapy for ovarian cancer, we conducted a Phase 1 trial to assess the pharmacokinetics and toxicity of intraperitoneal BRCA1sv retroviral vector therapy. Gene transfer and expression were documented by PCR, southern blot, RT-PCR and nuclease protection assays.
D L, Tait +5 more
openaire +2 more sources

